0001104659-23-098646.txt : 20230906 0001104659-23-098646.hdr.sgml : 20230906 20230906161648 ACCESSION NUMBER: 0001104659-23-098646 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230906 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 231239374 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2325492d1_8k.htm FORM 8-K
0001558569 false 0001558569 2023-09-06 2023-09-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 6, 2023

 

iSpecimen Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40501   27-0480143
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

450 Bedford Street
Lexington, MA 02420

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (781) 301-6700

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which
registered
Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On September 6, 2023, iSpecimen Inc., a Delaware corporation (the “Company”), announced its organizational changes to enhance operational efficiencies and drive profitability. The Company has eliminated several roles, primarily in technology and sales support, effective immediately. These headcount reductions represent approximately 20% of the Company’s total workforce. The Company also intends to substantially reduce its spending on technology and other operating expenses. As a result of these reductions and changes, the Company expects monthly expenses for headcount, including other turnover during the year, and all other operational costs, will decrease approximately 29% and 52%, respectively, compared to the first eight months of the year.

 

On September 6, 2023, the Company issued a press release announcing the organizational changes described in this Item 7.01 above. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The press release contains certain statements and information that speak to the Company’s expectations or predictions of the future. These statements and information may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are subject to risks and uncertainties, many of which are beyond the Company’s control, which could cause the Company’s actual results to differ materially from those expressed in or implied by these statements. Please see the Company’s disclosures regarding risk factors and forward-looking statements in its filings with the Securities and Exchange Commission (the “SEC”) (including Current Reports on Form 8-K, Quarterly Reports on Form 10-Q, and its most recent Annual Report on Form 10-K) for a discussion of the known material factors that could cause the Company’s actual results to differ materially from those indicated or implied by such forward-looking statements.

 

The information in this Item 7.01 and Exhibit 99.1 attached hereto will not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor will it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Forward-Looking Statements

 

This Current Report on Form 8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” “believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and the Company’s actual results may differ materially from those anticipated in these forward-looking statements.

 

There may be events in the future that the Company is not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under risk factors in the Company’s Amendment No. 1 to the Annual Report on Form 10-K/A for the year ended December 31, 2022 and other filings filed with the SEC, including the uncertainties associated with the Company’s lack of profitability, its continued capital needs, its lack of a long operating history, its growth strategy, inflation and recession and its impact on the business, Russia’s war with Ukraine and its impact on the operations, its technology development plans, and the regulatory environment in which it operates. Forward-looking statements speak only as of the date they are made. The Company does not assume any obligation to update forward-looking statements as circumstances change. The Company gives no assurance that it will achieve its expectations.

 

You may access the Company’s SEC filings by visiting SEC’s website at http://www.sec.gov. This Current Report does not constitute an offer or invitation for the sale or purchase of securities or to engage in any other transaction with the Company or its affiliates. The information in this Current Report is not targeted at the residents of any particular country or jurisdiction and is not intended for distribution to, or use by, any person in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.

 

 

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.
   
99.1 Press Release, dated September 6, 2023.
104 Cover Page Interactive Data File

 

Portions of this report may constitute “forward-looking statements” as defined by federal law. Although the Company believes any such statements are based on reasonable assumptions, there is no assurance that actual outcomes will not be materially different. Additional information about issues that could lead to material changes in the Company’s performance is contained in the Company’s filings with the SEC.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 6, 2023

 

  iSPECIMEN INC.
     
  By: /s/ Tracy Curley
    Name: Tracy Curley
    Title: Chief Executive Officer

 

 

 

 

EX-99.1 2 tm2325492d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1 

 

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

 

Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions

 

LEXINGTON, Mass., September 6, 2023iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that the Board of Directors has approved an organizational restructuring plan to improve operational performance and drive shareholder value.

 

iSpecimen announced immediate headcount reductions of approximately 20% of the Company’s total workforce and additional expense reductions after streamlining operations and rationalizing resources to focus on key market opportunities. Recently, the Company completed its implementation of lines of business teams and next day quotes to shorten sales cycles, improve quote-to-purchase order ratios, increase fulfillment and accelerate revenue generation. As a result of these changes, monthly expenses related to headcount, including other employee turnover during the year, as well as all other monthly operational costs, are expected to decrease by approximately 29% and 52%, respectively, compared to the average monthly costs for the first eight months of the year.

 

“The Company believes that the investments made during the first half of the year should allow the iSpecimen Marketplace to remain a leading source for researchers in need of biospecimens. We remain committed to becoming cash flow neutral and then cash flow positive as quickly as possible,” said Tracy Curley, iSpecimen’s CEO.

 

iSpecimen recently announced the launch of its virtual cancer sequencing procurement program aimed at providing researchers with consistent and direct access to cancer tumor tissues. The genetic signatures of cancer tumor tissues provide important information necessary to develop new treatments and diagnostics. Through this new offering, cancer researchers can advance their work by efficiently accessing these highly sought tumor tissues from iSpecimen, overcoming the existing manual, time-consuming and costly process of requesting biospecimen samples from multiple sources and suppliers.

 

Ms. Curley concluded, “Capitalizing on our market position and leveraging our broad supplier network, we saw a tremendous opportunity to launch our cancer sequencing program. We see strong demand for these highly valuable and challenging-to-obtain samples. This program relieves a major bottleneck in cancer research today, and we are working to realize revenue from this new opportunity as quickly as possible.”

 

About iSpecimen

 

iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.

 

Forward Looking Statements

 

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," “believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.

 

 

 

 

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risk factors contained in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements.

 

Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

For further information, please contact:

 

Investor Contacts

KCSA Strategic Communications

Phil Carlson / Erika Kay

iSpecimen@kcsa.com

 

Media Contacts

KCSA Strategic Communications

Raquel Cona / Shana Marino

iSpecimen@kcsa.com

 

###

 

 

 

 

EX-101.SCH 3 ispc-20230906.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ispc-20230906_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ispc-20230906_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Sep. 06, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 06, 2023
Entity File Number 001-40501
Entity Registrant Name iSpecimen Inc.
Entity Central Index Key 0001558569
Entity Tax Identification Number 27-0480143
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 450 Bedford Street
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02420
City Area Code 781
Local Phone Number 301-6700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol ISPC
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 7 tm2325492d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001558569 2023-09-06 2023-09-06 iso4217:USD shares iso4217:USD shares 0001558569 false 8-K 2023-09-06 iSpecimen Inc. DE 001-40501 27-0480143 450 Bedford Street Lexington MA 02420 781 301-6700 false false false false Common Stock, par value $0.0001 per share ISPC NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

")E>JQ"(6,P$ M "(" / " 8$0 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 M " 7@B97)!Z;HJT #X 0 &@ @ 'A$0 >&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " 7@B9799!YDAD! #/ M P $P @ '&$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 1 "0 ) #X" 0% ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ispecimen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2325492d1_8k.htm ispc-20230906.xsd ispc-20230906_lab.xml ispc-20230906_pre.xml tm2325492d1_ex99-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2325492d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "tm2325492d1_8k.htm" ] }, "labelLink": { "local": [ "ispc-20230906_lab.xml" ] }, "presentationLink": { "local": [ "ispc-20230906_pre.xml" ] }, "schema": { "local": [ "ispc-20230906.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ISPC", "nsuri": "http://ispecimen.com/20230906", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2325492d1_8k.htm", "contextRef": "AsOf2023-09-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ispecimen.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2325492d1_8k.htm", "contextRef": "AsOf2023-09-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ispecimen.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001104659-23-098646-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-098646-xbrl.zip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end